FDA Clearance Tracker · P140003-S072
Impella 2.5, Impella CP, Impella CP with SmartAssist, and Impella 5.5 with SmartAssist
Last checked: Nov 20, 2026Latest source record: Aug 4, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Aug 4, 2020
Approved
Time to decision
127 days
Received Mar 30, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140003-S072
- Device name
- Impella 2.5, Impella CP, Impella CP with SmartAssist, and Impella 5.5 with SmartAssist
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- Mar 30, 2020
- Decided
- Aug 4, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P140003
Device type
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for: 1) a new design for the Impella 2.5, Impella CP, and Impella CP with SmartAssist pigtail subcomponent; 2) the addition of a second supplier for the new pigtail design; and 3) a change in material and supplier of the encapsulant on the optical sensor used on the Impella CP with SmartAssist and the Impella 5.5 with SmartAssist catheters.
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.